Late DES thrombosis: A lot of smoke, very little fire?

Tim A. Fischell, David Holmes

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

Recent studies and editorials have stirred controversy and generated tremendous publicity in the lay press related to the safety of drug-eluting stents (DES) for the treatment of coronary artery disease. Questions have been raised regarding the risks of late, or very late stent thrombosis with DES. The purpose of this editorial and review of stent thrombosis is to illuminate some counterpoints to some of the attention surrounding the issues of late DES thrombosis. The risks of DES stent thrombosis versus BMS may have been overstated by flawed studies. Late stent thrombosis does occur with both BMS and DES, and may or may not be modestly higher with DES. The time course of very late "DES thrombosis," suggests that peristent plaque ruptures and disease progression in the target vessel may cause some, or many of these events. There is still much to be learned about the biology of DES. Although there is a small risk of late thrombosis with DES, there is little question that this technology provides benefit to the vast majority of patients compared with prior revascularization strategies, using balloon angioplasty, BMS, or bypass surgery. Substantial resources should be devoted to creating more biocompatible DES systems, and to minimizing the risks of both early and late stent thrombosis.

Original languageEnglish (US)
Pages (from-to)609-615
Number of pages7
JournalCatheterization and Cardiovascular Interventions
Volume69
Issue number4
DOIs
StatePublished - Mar 1 2007
Externally publishedYes

Fingerprint

Drug-Eluting Stents
Smoke
Thrombosis
Stents
Balloon Angioplasty
Disease Progression
Coronary Artery Disease
Rupture
Technology
Safety

Keywords

  • Complications adult cath/intervention
  • Restenosis
  • Thrombosis

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine

Cite this

Late DES thrombosis : A lot of smoke, very little fire? / Fischell, Tim A.; Holmes, David.

In: Catheterization and Cardiovascular Interventions, Vol. 69, No. 4, 01.03.2007, p. 609-615.

Research output: Contribution to journalReview article

@article{5dd1612c0e36491aa026c59f3fca2952,
title = "Late DES thrombosis: A lot of smoke, very little fire?",
abstract = "Recent studies and editorials have stirred controversy and generated tremendous publicity in the lay press related to the safety of drug-eluting stents (DES) for the treatment of coronary artery disease. Questions have been raised regarding the risks of late, or very late stent thrombosis with DES. The purpose of this editorial and review of stent thrombosis is to illuminate some counterpoints to some of the attention surrounding the issues of late DES thrombosis. The risks of DES stent thrombosis versus BMS may have been overstated by flawed studies. Late stent thrombosis does occur with both BMS and DES, and may or may not be modestly higher with DES. The time course of very late {"}DES thrombosis,{"} suggests that peristent plaque ruptures and disease progression in the target vessel may cause some, or many of these events. There is still much to be learned about the biology of DES. Although there is a small risk of late thrombosis with DES, there is little question that this technology provides benefit to the vast majority of patients compared with prior revascularization strategies, using balloon angioplasty, BMS, or bypass surgery. Substantial resources should be devoted to creating more biocompatible DES systems, and to minimizing the risks of both early and late stent thrombosis.",
keywords = "Complications adult cath/intervention, Restenosis, Thrombosis",
author = "Fischell, {Tim A.} and David Holmes",
year = "2007",
month = "3",
day = "1",
doi = "10.1002/ccd.21076",
language = "English (US)",
volume = "69",
pages = "609--615",
journal = "Catheterization and Cardiovascular Interventions",
issn = "1522-1946",
publisher = "Wiley-Liss Inc.",
number = "4",

}

TY - JOUR

T1 - Late DES thrombosis

T2 - A lot of smoke, very little fire?

AU - Fischell, Tim A.

AU - Holmes, David

PY - 2007/3/1

Y1 - 2007/3/1

N2 - Recent studies and editorials have stirred controversy and generated tremendous publicity in the lay press related to the safety of drug-eluting stents (DES) for the treatment of coronary artery disease. Questions have been raised regarding the risks of late, or very late stent thrombosis with DES. The purpose of this editorial and review of stent thrombosis is to illuminate some counterpoints to some of the attention surrounding the issues of late DES thrombosis. The risks of DES stent thrombosis versus BMS may have been overstated by flawed studies. Late stent thrombosis does occur with both BMS and DES, and may or may not be modestly higher with DES. The time course of very late "DES thrombosis," suggests that peristent plaque ruptures and disease progression in the target vessel may cause some, or many of these events. There is still much to be learned about the biology of DES. Although there is a small risk of late thrombosis with DES, there is little question that this technology provides benefit to the vast majority of patients compared with prior revascularization strategies, using balloon angioplasty, BMS, or bypass surgery. Substantial resources should be devoted to creating more biocompatible DES systems, and to minimizing the risks of both early and late stent thrombosis.

AB - Recent studies and editorials have stirred controversy and generated tremendous publicity in the lay press related to the safety of drug-eluting stents (DES) for the treatment of coronary artery disease. Questions have been raised regarding the risks of late, or very late stent thrombosis with DES. The purpose of this editorial and review of stent thrombosis is to illuminate some counterpoints to some of the attention surrounding the issues of late DES thrombosis. The risks of DES stent thrombosis versus BMS may have been overstated by flawed studies. Late stent thrombosis does occur with both BMS and DES, and may or may not be modestly higher with DES. The time course of very late "DES thrombosis," suggests that peristent plaque ruptures and disease progression in the target vessel may cause some, or many of these events. There is still much to be learned about the biology of DES. Although there is a small risk of late thrombosis with DES, there is little question that this technology provides benefit to the vast majority of patients compared with prior revascularization strategies, using balloon angioplasty, BMS, or bypass surgery. Substantial resources should be devoted to creating more biocompatible DES systems, and to minimizing the risks of both early and late stent thrombosis.

KW - Complications adult cath/intervention

KW - Restenosis

KW - Thrombosis

UR - http://www.scopus.com/inward/record.url?scp=33847642856&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33847642856&partnerID=8YFLogxK

U2 - 10.1002/ccd.21076

DO - 10.1002/ccd.21076

M3 - Review article

C2 - 17323356

AN - SCOPUS:33847642856

VL - 69

SP - 609

EP - 615

JO - Catheterization and Cardiovascular Interventions

JF - Catheterization and Cardiovascular Interventions

SN - 1522-1946

IS - 4

ER -